Charles E. McLaughlin net worth and biography

Charles McLaughlin Biography and Net Worth

CFO of Fortive
Chuck leads Fortive’s financial operations including financial planning, M&A, and capital allocation for strategic growth. He also serves as the executive sponsor of the Womxn’s Alliance Leadership Council employee and friends resource group. 

Before becoming Fortive’s founding SVP & CFO in 2016, Chuck served as group CFO of Danaher’s $4.7B Diagnostics platform and Beckman Coulter Diagnostics. He played a key role in several major acquisitions, including IRIS International, MicroScan, Devicor, and Hemocue. He previously served as VP and CFO of Tektronix, where he led the integration of what is now the Fortive Business System into the company’s financial planning and reporting functions.

Chuck holds an MBA from Willamette University and a BS in finance from the University of Oregon. He lives in the Everett, Washington area with his wife and enjoys golf, cross-country skiing, and basketball.

What is Charles E. McLaughlin's net worth?

The estimated net worth of Charles E. McLaughlin is at least $6.16 million as of November 11th, 2022. Mr. McLaughlin owns 88,818 shares of Fortive stock worth more than $6,156,864 as of February 6th. This net worth evaluation does not reflect any other investments that Mr. McLaughlin may own. Learn More about Charles E. McLaughlin's net worth.

What is Charles E. McLaughlin's salary?

As the CFO of Fortive Co., Mr. McLaughlin earned a total compensation package of $4,741,662.00 in 2020. Mr. McLaughlin earned a salary of $626,507.00, stock awards of $1,570,717.00, options awards of $1,184,054.00, non-equity compensation of $1,166,900.00, and other compensation of $193,484.00. Learn More on Charles E. McLaughlin's salary.

How do I contact Charles E. McLaughlin?

The corporate mailing address for Mr. McLaughlin and other Fortive executives is 6920 SEAWAY BLVD., EVERETT WA, 98203. Fortive can also be reached via phone at (425) 446-5000 and via email at [email protected] Learn More on Charles E. McLaughlin's contact information.

Has Charles E. McLaughlin been buying or selling shares of Fortive?

Charles E. McLaughlin has not been actively trading shares of Fortive over the course of the past ninety days. Learn More on Charles E. McLaughlin's trading history.

Who are Fortive's active insiders?

Fortive's insider roster includes Martin Gafinowitz (SVP), Barbara Hulit (CEO), James Lico (CEO), Charles McLaughlin (CFO), Christopher Mulhall (CAO), Patrick Murphy (SVP), William Pringle (SVP), Mitchell Rales (Director), Steven Rales (Director), Jonathan Schwarz (VP), Alan Spoon (Director), Peter Underwood (SVP), and Stacey Walker (SVP). Learn More on Fortive's active insiders.

Are insiders buying or selling shares of Fortive?

In the last twelve months, Fortive insiders bought shares 1 times. They purchased a total of 17,400 shares worth more than $1,013,550.00. In the last twelve months, insiders at the technology company sold shares 8 times. They sold a total of 52,059 shares worth more than $3,545,503.64. The most recent insider tranaction occured on November, 11th when CFO Charles E Mclaughlin sold 13,156 shares worth more than $900,396.64. Insiders at Fortive own 0.8% of the company. Learn More about insider trades at Fortive.

Information on this page was last updated on 11/11/2022.

Charles E. McLaughlin Insider Trading History at Fortive

See Full Table

Charles E. McLaughlin Buying and Selling Activity at Fortive

This chart shows Charles E. Mclaughlin's buying and selling at Fortive by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Fortive Company Overview

Fortive logo
Fortive Corp. engages in the design, development, manufacturing, and marketing of professional and engineered products, software, and services for a variety of end markets. It operates through the following segments: Intelligent Operating Solutions, Precision Technologies, and Advanced Healthcare Solutions. The Intelligent Operating Solutions segment provides solutions to accelerate industrial and facility reliability and performance, as well as compliance and safety across a range of vertical end markets, including manufacturing, process industries, healthcare, utilities and power, communications, and electronics. The Precision Technologies segment supplies technologies such as electrical test and measurement instruments and services, energetic material devices, and a broad portfolio of sensor and control system solutions. The Advanced Healthcare Solutions segment serves healthcare customers with products and services for critical activities, including instrument and device reprocessing, instrument tracking, cell therapy equipment design and manufacturing, biomedical test tools, radiation safety monitoring, and asset management. The company was founded on November 10, 2015, and is
Read More

Today's Range

Now: $68.94
Low: $68.51
High: $69.48

50 Day Range

MA: $65.98
Low: $63.45
High: $69.08

2 Week Range

Now: $68.94
Low: $52.47
High: $69.48

Volume

2,724,937 shs

Average Volume

1,996,314 shs

Market Capitalization

$24.39 billion

P/E Ratio

32.83

Dividend Yield

0.41%

Beta

1.12